Biolexis Therapeutics Inc.

CIK 1914060 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Biolexis Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Jun 3, 2026D0001914060-26-000001
Oct 17, 2023D0001914060-23-000006
Oct 3, 2023D0001914060-23-000005
Sep 2, 2022D0001914060-22-000002
Mar 1, 2022D0001914060-22-000001